Avidity Biosciences Inc (RNA)

Finanzdaten der Avidity Biosciences Inc-Aktie (RNA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	61.56% 3.543	2.193	2.818	2.316	2.233
Operating Expenses	17.11% 80.73	68.94	61.44	54.95	59.83
Benefits Costs and Expenses	15.59% 72.40	62.64	-	-	54.63
Costs And Expenses	15.59% 72.40	62.64	61.44	54.95	54.63
Operating Income/Loss	15.65% -77.19	-66.74	-58.62	-52.63	-57.60
Nonoperating Income/Loss	32.25% 8.332	6.30	6.267	5.609	5.202
Income/Loss From Continuing Operations Before Tax	13.92% -68.86	-60.44	2.818	-47.02	-52.39
Income/Loss From Continuing Operations After Tax	13.92% -68.86	-60.44	-52.36	-47.02	-52.39
Net Income/Loss	13.92% -68.86	-60.44	-52.36	-47.02	-52.39
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	8,408% 87.21	1.025	74.10	71.39	70.43
Diluted Average Shares	8,408% 87.21	1.025	74.10	71.39	70.43
Basic Earnings Per Share	1.25% -0.79	-0.80	-0.71	-0.66	-0.74
Diluted Earnings Per Share	1.25% -0.79	-0.80	-0.71	-0.66	-0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-